BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 12825236)

  • 1. Susceptibility of lupus-prone NZM mouse strains to lead exacerbation of systemic lupus erythematosus symptoms.
    Hudson CA; Cao L; Kasten-Jolly J; Kirkwood JN; Lawrence DA
    J Toxicol Environ Health A; 2003 May; 66(10):895-918. PubMed ID: 12825236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NZM2328: a new mouse model of systemic lupus erythematosus with unique genetic susceptibility loci.
    Waters ST; Fu SM; Gaskin F; Deshmukh US; Sung SS; Kannapell CC; Tung KS; McEwen SB; McDuffie M
    Clin Immunol; 2001 Sep; 100(3):372-83. PubMed ID: 11513551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in expression of lupus nephritis in New Zealand mixed H-2z homozygous inbred strains of mice derived from New Zealand black and New Zealand white mice. Origins and initial characterization.
    Rudofsky UH; Evans BD; Balaban SL; Mottironi VD; Gabrielsen AE
    Lab Invest; 1993 Apr; 68(4):419-26. PubMed ID: 8479150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA hypomethylation is crucial for apoptotic DNA to induce systemic lupus erythematosus-like autoimmune disease in SLE-non-susceptible mice.
    Wen ZK; Xu W; Xu L; Cao QH; Wang Y; Chu YW; Xiong SD
    Rheumatology (Oxford); 2007 Dec; 46(12):1796-803. PubMed ID: 18032537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
    Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
    Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Zealand mixed mice: a genetic systemic lupus erythematosus model for assessing environmental effects.
    Rudofsky UH; Lawrence DA
    Environ Health Perspect; 1999 Oct; 107 Suppl 5(Suppl 5):713-21. PubMed ID: 10502536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional dissection of systemic lupus erythematosus using congenic mouse strains.
    Morel L; Mohan C; Yu Y; Croker BP; Tian N; Deng A; Wakeland EK
    J Immunol; 1997 Jun; 158(12):6019-28. PubMed ID: 9190957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brief and long maternal separations decrease corticosterone secretion in a lupus-prone strain: dissociation from disease-related parameters.
    Catallani B; Palma BD; Gil FZ; Suchecki D
    Brain Behav Immun; 2008 Mar; 22(3):367-74. PubMed ID: 17920241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibody-mediated neuroinflammation: pathogenesis of neuropsychiatric systemic lupus erythematosus in the NZM88 murine model.
    Mondal TK; Saha SK; Miller VM; Seegal RF; Lawrence DA
    Brain Behav Immun; 2008 Aug; 22(6):949-59. PubMed ID: 18411022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrinsic defects in macrophage IL-12 production associated with immune dysfunction in the MRL/++ and New Zealand Black/White F1 lupus-prone mice and the Leishmania major-susceptible BALB/c strain.
    Alleva DG; Kaser SB; Beller DI
    J Immunol; 1998 Dec; 161(12):6878-84. PubMed ID: 9862720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dietary supplement ephedrine induces beta-adrenergic mediated exacerbation of systemic lupus erythematosus in NZM391 mice.
    Hudson CA; Mondal TK; Cao L; Kasten-Jolly J; Huber VC; Lawrence DA
    Lupus; 2005; 14(4):293-307. PubMed ID: 15864916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic susceptibility to polyI:C-induced IFNalpha/beta-dependent accelerated disease in lupus-prone mice.
    Jørgensen TN; Thurman J; Izui S; Falta MT; Metzger TE; Flannery SA; Kappler J; Marrack P; Kotzin BL
    Genes Immun; 2006 Oct; 7(7):555-67. PubMed ID: 16900204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The genetic regulation of the induction of experimental SLE.
    Mendlovic S; Brocke S; Fricke H; Shoenfeld Y; Bakimer R; Mozes E
    Immunology; 1990 Feb; 69(2):228-36. PubMed ID: 2307482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mercury induces polyclonal B cell activation, autoantibody production and renal immune complex deposits in young (NZB x NZW)F1 hybrids.
    al-Balaghi S; Möller E; Möller G; Abedi-Valugerdi M
    Eur J Immunol; 1996 Jul; 26(7):1519-26. PubMed ID: 8766555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoreactive responses to environmental factors: 3. Mouse strain-specific differences in induction and regulation of anti-DNA antibody responses due to phthalate-isomers.
    Lim SY; Ghosh SK
    J Autoimmun; 2005 Aug; 25(1):33-45. PubMed ID: 15993037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced susceptibility to end-organ disease in the lupus-facilitating NZW mouse strain.
    Xie C; Zhou XJ; Liu X; Mohan C
    Arthritis Rheum; 2003 Apr; 48(4):1080-92. PubMed ID: 12687552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic basis of murine lupus.
    Santiago-Raber ML; Laporte C; Reininger L; Izui S
    Autoimmun Rev; 2004 Jan; 3(1):33-9. PubMed ID: 14871647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of systemic lupus erythematosus-like syndrome in syngeneic mice by immunization with activated lymphocyte-derived DNA.
    Qiao B; Wu J; Chu YW; Wang Y; Wang DP; Wu HS; Xiong SD
    Rheumatology (Oxford); 2005 Sep; 44(9):1108-14. PubMed ID: 15840592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lupus-prone strains vary in susceptibility to antibody-mediated end organ disease.
    Xie C; Du Y; Kumar K; Li L; Han J; Liu K; Zhou XJ; Mohan C
    Genes Immun; 2013 Apr; 14(3):170-8. PubMed ID: 23392277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerated deaths from systemic lupus erythematosus in NZB x NZW F1 mice treated with the testosterone-blocking drug flutamide.
    Walker SE; Besch-Williford CL; Keisler DH
    J Lab Clin Med; 1994 Sep; 124(3):401-7. PubMed ID: 8083583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.